{
    "itemId": "MISSION-500-115-1771349552717",
    "itemType": "matrixMatch",
    "difficulty": 5,
    "questionText": "The nurse is reviewing the electronic health record for an 82-year-old client admitted for evaluation of nausea, anorexia, and visual disturbances. For each finding below, click to specify if it is consistent with the client's potential condition. Each finding may support more than one condition.",
    "exhibits": [
        {
            "id": "exhibit_1",
            "type": "EHR",
            "tabs": [
                {
                    "title": "Nurses' Notes",
                    "content": "<b>0800:</b> Client is an 82-year-old male with a history of HFrEF, atrial fibrillation, and Stage 3 CKD. Admitted from home with complaints of progressive nausea, anorexia, and 'seeing yellowish halos around lights' for the past 2 days. States he was started on furosemide two weeks ago. Lives in a rural area and missed his 1-week follow-up appointment due to lack of transportation. Client is alert, oriented to person and place only."
                },
                {
                    "title": "Vital Signs",
                    "content": "<h4>Vital Signs Trend</h4>\n| Time | T (Â°C) | HR (apical) | RR | BP | SpO2 |\n|---|---|---|---|---|---|\n| Yesterday 2000 | 36.8 | 62 | 18 | 118/72 | 96% RA |\n| Today 0400 | 36.7 | 54 | 16 | 114/70 | 97% RA |\n| Today 0800 | 36.6 | 48 | 18 | 110/68 | 96% RA |"
                },
                {
                    "title": "Laboratory Results",
                    "content": "<h4>Results from 0730</h4>\n<ul>\n<li><b>Sodium:</b> 138 mEq/L (136-145 mEq/L)</li>\n<li><b>Potassium:</b> 2.9 mEq/L (3.5-5.0 mEq/L) - <em>Critical Low</em></li>\n<li><b>BUN:</b> 45 mg/dL (10-20 mg/dL)</li>\n<li><b>Creatinine:</b> 1.8 mg/dL (0.6-1.2 mg/dL)</li>\n<li><b>Digoxin Level:</b> 2.4 ng/mL (Therapeutic: 0.8-2.0 ng/mL)</li>\n</ul>"
                },
                {
                    "title": "Diagnostics",
                    "content": "<b>ECG Interpretation (0745):</b> Sinus bradycardia with a heart rate of 48/min. First-degree atrioventricular (AV) block with a PR interval of 0.24 seconds. Downsloping ST-segment depression noted in leads V5-V6."
                },
                {
                    "title": "MAR",
                    "content": "<h4>Scheduled Medications - 0900</h4>\n<ul>\n<li>Lisinopril 10 mg PO DAILY</li>\n<li>Digoxin 0.125 mg PO DAILY</li>\n<li>Furosemide 40 mg PO DAILY</li>\n<li>Apixaban 5 mg PO BID</li>\n</ul>"
                }
            ]
        }
    ],
    "matrix": {
        "rows": [
            {
                "id": "row1",
                "label": "Serum Potassium 2.9 mEq/L"
            },
            {
                "id": "row2",
                "label": "Apical heart rate of 48/min"
            },
            {
                "id": "row3",
                "label": "Reports of 'yellowish halos'"
            },
            {
                "id": "row4",
                "label": "BUN 45 mg/dL & Creatinine 1.8 mg/dL"
            },
            {
                "id": "row5",
                "label": "First-degree AV block on ECG"
            }
        ],
        "columns": [
            {
                "id": "col1",
                "label": "Indicates Digoxin Toxicity"
            },
            {
                "id": "col2",
                "label": "Indicates Renal Impairment"
            },
            {
                "id": "col3",
                "label": "Indicates Need to Withhold Medication"
            }
        ]
    },
    "correctResponse": {
        "row1": [
            "col1",
            "col3"
        ],
        "row2": [
            "col1",
            "col3"
        ],
        "row3": [
            "col1",
            "col3"
        ],
        "row4": [
            "col1",
            "col2",
            "col3"
        ],
        "row5": [
            "col1",
            "col3"
        ]
    },
    "answerBreakdown": {
        "row1": {
            "col1": "Correct. Hypokalemia (Potassium < 3.5 mEq/L) is a critical finding that significantly potentiates the effects of digoxin on the myocardium, increasing the risk and severity of toxicity even with therapeutic drug levels. The client's K+ of 2.9 mEq/L is a major contributor to their toxic state.",
            "col2": "Incorrect. Hypokalemia itself is an electrolyte imbalance, not a direct indicator of renal impairment. Renal impairment is indicated by elevated BUN and creatinine.",
            "col3": "Correct. The presence of significant hypokalemia is a major safety concern that necessitates withholding the scheduled dose of digoxin, as administering it would worsen the life-threatening cardiotoxicity."
        },
        "row2": {
            "col1": "Correct. Digoxin has a negative chronotropic effect (slows heart rate). Severe bradycardia (HR < 60/min), especially a rate of 48/min, is a classic sign of digoxin toxicity as the drug's effect on the sinoatrial (SA) node becomes excessive.",
            "col2": "Incorrect. Bradycardia is a cardiovascular sign, not a direct indicator of renal function. While renal impairment can cause digoxin toxicity which leads to bradycardia, the heart rate itself does not indicate the state of the kidneys.",
            "col3": "Correct. An apical heart rate below 60/min is a standard parameter for withholding digoxin. A rate of 48/min is a definitive 'STOP' sign, requiring the nurse to hold the medication and notify the provider immediately."
        },
        "row3": {
            "col1": "Correct. Visual disturbances, specifically xanthopsia (seeing yellow-green halos around objects), are a classic, though less common, neurotoxic symptom of digoxin toxicity.",
            "col2": "Incorrect. Visual disturbances like xanthopsia are specific to digoxin toxicity and are not associated with renal impairment itself.",
            "col3": "Correct. The client's report of a hallmark symptom of toxicity is a clear indication that administering more of the drug would be dangerous. This finding mandates withholding the medication."
        },
        "row4": {
            "col1": "Correct. Elevated BUN and Creatinine indicate renal impairment. Since digoxin is primarily cleared by the kidneys, poor renal function leads to drug accumulation and is a primary risk factor for developing toxicity. The client's high levels confirm this risk factor is present and contributing to the toxic state.",
            "col2": "Correct. Elevated Blood Urea Nitrogen (BUN) and serum creatinine are the hallmark laboratory indicators of impaired kidney function (renal impairment).",
            "col3": "Correct. The evidence of poor renal clearance means the client cannot effectively excrete the drug. Administering another dose would raise the blood level further into a dangerous range, so the medication must be withheld."
        },
        "row5": {
            "col1": "Correct. Digoxin slows conduction through the atrioventricular (AV) node. In toxicity, this effect is exaggerated and can manifest as a first-degree AV block (PR interval > 0.20 seconds) or progress to more severe heart blocks. The client's PR interval of 0.24 seconds is a sign of toxic effect on the heart's conduction system.",
            "col2": "Incorrect. AV block is a cardiac conduction abnormality and not a direct indicator of renal function, although it can be caused by the digoxin toxicity that resulted from renal impairment.",
            "col3": "Correct. Evidence of cardiotoxicity on the ECG, such as a new or worsening AV block, is an absolute contraindication to administering the next dose of digoxin. The nurse must withhold the dose to prevent progression to a life-threatening complete heart block."
        }
    }
}